Daily use of MS14, a natural product derived from Persian medicine, safely led to gains in physical activity and walking…
Articles by Lindsey Shapiro, PhD
Levels of neurofilament light chain (NfL), a biomarker of nerve cell damage, may help predict multiple sclerosis (MS) prognosis…
Consuming alcohol around dosing time could limit the effectiveness of Tecfidera (dimethyl fumarate) for multiple sclerosis patients, a…
Daily treatment with an oral antidepressant called bupropion — marketed as Wellbutrin and Zyban, among others — significantly improved…
Temperature variability and increasing exposure to airborne pollutants — both consequences of climate change — can worsen disease symptoms and…
Scientists have identified a number of antibodies that can bind to the Epstein-Barr virus (EBV) — a major risk…
Tiziana Life Sciences plans to request a meeting with the U.S. Food and Drug Administration (FDA) later this year…
In an early clinical trial, Atara Biotherapeutics’ investigational treatment ATA188 stabilized or eased disability in most people with nonactive,…
Long-term use of the investigational BTK inhibitor evobrutinib among people with relapsing forms of multiple sclerosis (MS) continues…
Up to two years of Vumerity (diroximel fumarate) treatment was generally well-tolerated and led to significant decreases in disease activity…
Ocrevus (ocrelizumab), an anti-CD20 therapy developed by Genentech, seems to be superior to rituximab at lowering relapse rates…
In the years after a diagnosis of clinically isolated syndrome (CIS) — a first episode of neurological symptoms suggestive…
Early use of disease-modifying therapies (DMTs) among people with secondary progressive multiple sclerosis (SPMS) may lead to overall…
Exposure to high-efficacy disease-modifying therapies (DMTs) is associated with an increased risk of cervical abnormalities in women with…
Genetic variants in genes mostly active in the brain and spinal cord — the central nervous system — are associated…
The investigational immunotherapy ATA188 continues to ease disability and prevent brain tissue shrinkage in people with progressive forms of…
Tap speed — or how quickly one types on a smartphone keyboard — may be a useful tool for monitoring…
An infection with the Epstein-Barr virus (EBV) consistently preceded elevations in neurofilament light chain (NfL), an early biomarker of…
Remyelination, or regeneration of the myelin sheath that’s progressively damaged and lost in multiple sclerosis (MS), may be…
Fertility treatments do not significantly increase the risk of relapse in women with multiple sclerosis (MS), even among those…
For National Physical Therapy Month, Helius Medical Technologies is spotlighting physical therapists who make possible the success of the company’s…
GoodRx, in collaboration with Biogen, has made the enrollment form for starting a multiple sclerosis (MS) patient on…
People with multiple sclerosis (MS) are significantly more likely to have antibodies against the Epstein-Barr virus (EBV) — the…
Neurologists in Colombia agree that sexual dysfunction is burdensome and affects quality of life in major ways for people…
XRHealth‘s virtual reality (VR) software, which provides an immersive three-dimensional environment where patients do repetitive tasks such as popping…
Evaluating a person’s sense of smell may help monitor disease progression in people with multiple sclerosis (MS), according to…
Kesimpta (ofatumumab) is more cost-effective for treating relapsing-remitting multiple sclerosis (RRMS) than most other disease-modifying therapies (DMTs)…
People with multiple sclerosis (MS) may be more likely to use unhealthy or ineffective coping mechanisms than healthy individuals…
Novartis said it will petition the U.S. Supreme Court to uphold a patent that protects the dosing regimen of…
Six months of treatment with foralumab nasal spray led to significant functional improvements in the second patient with non-active…